- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Glucotrack, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| Do | Glucotrack, Inc.: Glucotrack to Participate in the Q3 Virtual Investor Summit | 3 | GlobeNewswire (USA) | ||
| 05.09. | Glucotrack, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 15.08. | Glucotrack GAAP EPS of -$9.62 | 1 | Seeking Alpha | ||
| 14.08. | Glucotrack to submit long-term CGM implant for FDA IDE this year | 1 | MassDevice | ||
| 14.08. | Glucotrack, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 14.08. | GlucoTrack, Inc.: Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | 199 | GlobeNewswire (Europe) | On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device... ► Artikel lesen | |
| 06.08. | Cardiac electrophysiologist Hirsh joins Glucotrack's clinical team | 1 | Investing.com | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 06.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.08. | Glucotrack, Inc.: Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology | 152 | GlobeNewswire (Europe) | RUTHERFORD, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people... ► Artikel lesen | |
| 31.07. | Glucotrack, Inc.: Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting | 1 | GlobeNewswire (USA) | ||
| 24.07. | Glucotrack, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 08.07. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | Glucotrack, Inc.: Glucotrack Announces Repurchase of Series A Warrants | 1 | GlobeNewswire (USA) | ||
| 27.06. | Pre-market Movers: Blue Gold, INmune Bio, Cyngn, NanoVibronix, GlucoTrack | 842 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.20 A.M. ET).In the Green Blue Gold Limited (BGL) is up over 297% at $80.01.
INmune... ► Artikel lesen | |
| 25.06. | GlucoTrack Stock Jumps 40% On Strong Clinical Data For Implantable Glucose Monitor | 2 | RTTNews | ||
| 25.06. | Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday? | 3 | Benzinga.com | ||
| 25.06. | Glucotrack reports positive results from first human trial of blood glucose monitor | 3 | Investing.com | ||
| 25.06. | Glucotrack berichtet über positive Ergebnisse der ersten klinischen Studie am Menschen | 2 | Investing.com Deutsch | ||
| 25.06. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 17,170 | +0,35 % | EQS-News: Eckert & Ziegler SE: Berenberg startet Coverage mit "Kauf"-Empfehlung und Kursziel von 24 € - Kurspotenzial 47% | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Research Update
Eckert & Ziegler: Berenberg startet Coverage mit "Kauf"-Empfehlung und Kursziel von 24 € - Kurspotenzial 47%
09.09.2025... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,109 | -2,68 % | Sernova Corp.: Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference | ||
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung geben | EQS-News: SYNLAB AG
/ Schlagwort(e): Kooperation/Studienergebnisse
Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,029 | -2,72 % | Massive News: Volumen- und Kursexplosion durch "InsuJet 2.0"?! | ||
| ATOSSA THERAPEUTICS | 0,700 | -2,10 % | Atossa Genetics stock rating reiterated by H.C. Wainwright on FDA meeting plans | ||
| PING AN HEALTHCARE | 2,523 | +3,32 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting | -- Special Meeting to be held on September 26, 2025 --
SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- In an update to stockholders today, Evofem Biosciences, Inc.... ► Artikel lesen | |
| UNIDOC HEALTH | 0,130 | -3,98 % | XFRA L7T: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced | BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,011 | -13,64 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,300 | +1,35 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| VERU | 3,490 | -1,97 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| QUIDELORTHO | 24,800 | +1,64 % | QuidelOrtho Corporation: QuidelOrtho Completes Debt Refinancing | SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic... ► Artikel lesen | |
| CYTOSORBENTS | 0,787 | -0,88 % | CytoSorbents bei H.C. Wainwright: Strategisches Wachstum und regulatorische Herausforderungen |
Das Unternehmen GLUCOTRACK INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +117,45 % bei einem Aktienkurs von 10,590 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.